Latest News
Featured News
Scancell announces FDA clearance of IND application for global Phase 3 trial of iSCIB1+ in advanced melanoma
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Select the category
Scancell announces Genmab exercises option to a second commercial license agreement
Scancell announces further positive data from the ongoing SCOPE trial of SCIB1 with double CPIs for Advanced Melanoma
Result of 2024 Annual General Meeting
Scancell announces strengthening of leadership team as it closes on value-generating inflection points
Notice of AGM
Scancell Preliminary Results for the Year Ended 30 April 2024
No results found.
Regulatory News Archive
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.